Comparison of two platelet gylcoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization.

Saved in:
Bibliographic Details
Title: Comparison of two platelet gylcoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization.
Authors: Topol EJ (AUTHOR), Moliterno DJ (AUTHOR), Herrmann HC (AUTHOR), Powers ER (AUTHOR), Grines CL (AUTHOR), Cohen DJ (AUTHOR), Cohen EA (AUTHOR), Bertrand M (AUTHOR), Neumann F (AUTHOR), Stone GW (AUTHOR), DiBattiste PM (AUTHOR), Demopoulos L (AUTHOR), Do Tirofiban and ReoPro Give Similar Efficacy Trial Investigators (CORPORATE AUTHOR)
Source: New England Journal of Medicine. 06/21/2001, Vol. 344 Issue 25, p1888-1894. 7p.
Database: Academic Search Ultimate
Description
ISSN:00284793